Correction: Ribeiro et al. Liposomal Formulations of a New Zinc(II) Complex Exhibiting High Therapeutic Potential in a Murine Colon Cancer Model. Int. J. Mol. Sci. 2022, 23, 6728
Key Points
To evaluate the therapeutic efficacy of a new zinc(II) complex formulated in liposomal carriers for treating colon cancer in a murine model.
Administered liposomal formulations of zinc(II) complex in a murine colon cancer model.
Assessed pharmacological impact and tumor response.
Employed appropriate statistical analyses to evaluate outcomes.
Significant tumor reduction observed in treatment group versus control arm (p<0.05).
Enhanced bioavailability and retention of the zinc complex in tumors.
Improved survival rates in treated mice compared to controls.
Correction: Ribeiro et al. Liposomal Formulations of a New Zinc(II) Complex Exhibiting High Therapeutic Potential in a Murine Colon Cancer Model. Int. J. Mol. Sci. 2022, 23, 6728 | Synapse
Also Consider
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: